Clinical Trial Update: Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0) [NA]

View source ↗

Summary

A completed clinical trial sponsored by Institut Curie evaluated circulating tumor DNA levels as a biomarker in patients with hepatic metastatic uveal melanoma …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Snippet

Sponsor: Institut Curie | Conditions: Uveal Melanoma | NA | Status: COMPLETED